C Kendell1, K M Decker2,3, P A Groome4, M L McBride5, L Jiang4, M K Krzyzanowska6,7, G Porter1,8, D Turner3,9, R Urquhart1,8, M Winget10, E Grunfeld11. 1. Cancer Outcomes Research Program, Dalhousie University and Nova Scotia Health Authority, Halifax, NS. 2. Department of Community Health Sciences, University of Manitoba, Winnipeg, MB. 3. Epidemiology and Cancer Registry, Cancer-Care Manitoba, Winnipeg, MB. 4. Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON. 5. Cancer Control Research, BC Cancer Agency, Vancouver, BC. 6. University Health Network, Toronto, ON. 7. Cancer Care Ontario, Toronto, ON. 8. Department of Surgery, Dalhousie University, Halifax, NS. 9. University of Manitoba, Winnipeg, MB. 10. Stanford University School of Medicine, Stanford, CA, U.S.A. 11. Department of Family and Community Medicine, University of Toronto, Toronto, ON.
Abstract
INTRODUCTION: Oncologists have traditionally been responsible for providing routine follow-up care for cancer survivors; in recent years, however, primary care providers (pcps) are taking a greater role in care during the follow-up period. In the present study, we used a longitudinal multi-province retrospective cohort study to examine how primary care and specialist care intersect in the delivery of breast cancer follow-up care. METHODS: Various databases (registry, clinical, and administrative) were linked in each of four provinces: British Columbia, Manitoba, Ontario, and Nova Scotia. Population-based cohorts of breast cancer survivors were identified in each province. Physician visits were identified using billings or claims data and were classified as visits to primary care (total, breast cancer-specific, and other), oncology (medical oncology, radiation oncology, and surgery), and other specialties. The mean numbers of visits by physician type and specialty, or by combinations thereof, were examined. The mean numbers of visits for each follow-up year were also examined by physician type. RESULTS: The results showed that many women (>64%) in each province received care from both primary care and oncology providers during the follow-up period. The mean number of breast cancer-specific visits to primary care and visits to oncology declined with each follow-up year. Interprovincial variations were observed, with greater surgeon follow-up in Nova Scotia and greater primary care follow-up in British Columbia. Provincial differences could reflect variations in policies and recommendations, relevant initiatives, and resources or infrastructure to support pcp-led follow-up care. CONCLUSIONS: Optimizing the role of pcps in breast cancer follow-up care might require strategies to change attitudes about pcp-led follow-up and to better support pcps in providing survivorship care.
INTRODUCTION: Oncologists have traditionally been responsible for providing routine follow-up care for cancer survivors; in recent years, however, primary care providers (pcps) are taking a greater role in care during the follow-up period. In the present study, we used a longitudinal multi-province retrospective cohort study to examine how primary care and specialist care intersect in the delivery of breast cancer follow-up care. METHODS: Various databases (registry, clinical, and administrative) were linked in each of four provinces: British Columbia, Manitoba, Ontario, and Nova Scotia. Population-based cohorts of breast cancer survivors were identified in each province. Physician visits were identified using billings or claims data and were classified as visits to primary care (total, breast cancer-specific, and other), oncology (medical oncology, radiation oncology, and surgery), and other specialties. The mean numbers of visits by physician type and specialty, or by combinations thereof, were examined. The mean numbers of visits for each follow-up year were also examined by physician type. RESULTS: The results showed that many women (>64%) in each province received care from both primary care and oncology providers during the follow-up period. The mean number of breast cancer-specific visits to primary care and visits to oncology declined with each follow-up year. Interprovincial variations were observed, with greater surgeon follow-up in Nova Scotia and greater primary care follow-up in British Columbia. Provincial differences could reflect variations in policies and recommendations, relevant initiatives, and resources or infrastructure to support pcp-led follow-up care. CONCLUSIONS: Optimizing the role of pcps in breast cancer follow-up care might require strategies to change attitudes about pcp-led follow-up and to better support pcps in providing survivorship care.
Entities:
Keywords:
Breast cancer; follow-up care; primary care; survivors
Authors: James L Khatcheressian; Antonio C Wolff; Thomas J Smith; Eva Grunfeld; Hyman B Muss; Victor G Vogel; Francine Halberg; Mark R Somerfield; Nancy E Davidson Journal: J Clin Oncol Date: 2006-10-10 Impact factor: 44.544
Authors: E Grunfeld; R Fitzpatrick; D Mant; P Yudkin; R Adewuyi-Dalton; J Stewart; D Cole; M Vessey Journal: Br J Gen Pract Date: 1999-09 Impact factor: 5.386
Authors: Arnold L Potosky; Paul K J Han; Julia Rowland; Carrie N Klabunde; Tenbroeck Smith; Noreen Aziz; Craig Earle; John Z Ayanian; Patricia A Ganz; Michael Stefanek Journal: J Gen Intern Med Date: 2011-07-22 Impact factor: 5.128
Authors: Winson Y Cheung; Noreen Aziz; Anne-Michelle Noone; Julia H Rowland; Arnold L Potosky; John Z Ayanian; Katherine S Virgo; Patricia A Ganz; Michael Stefanek; Craig C Earle Journal: J Cancer Surviv Date: 2013-03-24 Impact factor: 4.442
Authors: Winson Y Cheung; Bridget A Neville; Danielle B Cameron; E Francis Cook; Craig C Earle Journal: J Clin Oncol Date: 2009-03-30 Impact factor: 44.544
Authors: M Powis; P Groome; N Biswanger; C Kendell; K M Decker; E Grunfeld; M L McBride; R Urquhart; M Winget; G A Porter; M K Krzyzanowska Journal: Curr Oncol Date: 2019-10-01 Impact factor: 3.677
Authors: Anna Jansana; Laia Domingo; Berta Ibañez; Alexandra Prados; Isabel Del Cura; Maria Padilla-Ruiz; Teresa Sanz; Beatriz Poblador; Ibai Tamayo; Antonio Gimeno; Angel Alberquilla; Mercè Abizanda; Mercè Comas; Manuela Lanzuela; Rossana Burgui; Antonio Diaz Holgado; Talita Duarte-Salles; Conchi Moreno; Javier Louro; Javier Baquedano; Cristobal Molina; Maria Del Carmen Martinez; Javier Gorricho; Maximino Redondo; Xavier Castells; Maria Sala Journal: J Cancer Surviv Date: 2021-03-23 Impact factor: 4.442
Authors: K Decker; R Moineddin; C Kendell; R Urquhart; N Biswanger; P Groome; M L McBride; M Winget; M Whitehead; E Grunfeld Journal: BMC Fam Pract Date: 2019-11-21 Impact factor: 2.497
Authors: Patti Ann Groome; Mary L McBride; Li Jiang; Cynthia Kendell; Kathleen M Decker; Eva Grunfeld; Monika K Krzyzanowska; Marcy Winget Journal: Int J Popul Data Sci Date: 2018-11-12